Optina. Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 29

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $257K

  • Investors
  • 23

Optina. General Information

Description

Developer of ocular imaging systems and diagnostic technology designed to help detect key biomarkers of Alzheimer's disease. The company's platform combines data-rich images with AI imaging systems to detect age-related macular degeneration and ocular diabetic retinopathy and identify beta-amyloid plaques, enabling doctors to treat the cause of memory loss through a simple eye exam.

Contact Information

Website
www.optina.net
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 8200 Decarie Boulevard
  • Suite 220
  • Montreal, Quebec H4P 2P5
  • Canada
+1 (514)
Primary Industry
Decision/Risk Analysis
Other Industries
Diagnostic Equipment
Vertical(s)
Artificial Intelligence & Machine Learning, HealthTech
Corporate Office
  • 8200 Decarie Boulevard
  • Suite 220
  • Montreal, Quebec H4P 2P5
  • Canada
+1 (514)

Optina. Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Optina. Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
14. Later Stage VC 01-Jan-2023 $257K Completed Generating Revenue
13. Later Stage VC 24-Jan-2022 Completed Generating Revenue
12. Accelerator/Incubator 01-Jan-2022 Completed Generating Revenue
11. Later Stage VC (Series A) 28-Oct-2021 Completed Generating Revenue
10. Later Stage VC 20-Jun-2020 Completed Generating Revenue
9. Later Stage VC 12-Jun-2019 Completed Generating Revenue
8. Seed Round 10-Oct-2018 Completed Clinical Trials - Phase 3
7. Accelerator/Incubator 22-Jan-2018 Completed Clinical Trials - Phase 3
6. Debt - General 31-Dec-2017 $114K $303K Completed Startup
5. Accelerator/Incubator 01-Jan-2017 $190K Completed Startup
To view Optina.’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Optina. Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of ocular imaging systems and diagnostic technology designed to help detect key biomarkers of Alzheimer's dise
Decision/Risk Analysis
Montreal, Canada
29 As of 2025

Rehovot, Israel
 

Cambridge, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Optina. Competitors (3)

One of Optina.’s 3 competitors is Nucleix, a Venture Capital-Backed company based in Rehovot, Israel.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Nucleix Venture Capital-Backed Rehovot, Israel
Inivata Formerly VC-backed Cambridge, United Kingdom
ROCA Test Formerly VC-backed Cambridge, United Kingdom
You’re viewing 3 of 3 competitors. Get the full list »

Optina. Patents

  • 17

    Total Documents Applications and Grants

  • Total Patents Families

  • 11

    Granted

  • 5

    Pending

  • Expiring in next 12 mo

Optina. Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250127396-A1 Retinal camera using a light guide to illuminate the eye with a defined light emission geometry Pending 03-Mar-2022
US-20220157470-A1 Method and system for identifying subjects who are potentially impacted by a medical condition Active 19-Mar-2019
EP-3942569-A1 Method and system for identifying subjects who are potentially impacted by a medical condition Pending 19-Mar-2019
EP-3942569-A4 Method and system for identifying subjects who are potentially impacted by a medical condition Pending 19-Mar-2019
CA-3134081-A1 Method and system for identifying subjects who are potentially impacted by a medical condition Pending 19-Mar-2019 G16H50/70
To view Optina.’s complete patent history, request access »

Optina. Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Optina. Investors (23)

Investor Name Investor Type Holding Investor Since Participating Rounds
CABHI Corporate Venture Capital
Alzheimers Drug Discovery Foundation Not-For-Profit Venture Capital Minority
Keihanna Global Acceleration Program Accelerator/Incubator
Alfin Asset Management Asset Manager Minority
Boehringer Ingelheim Venture Fund Corporate Venture Capital Minority
You’re viewing 5 of 23 investors. Get the full list »

Ready to get started?

Request a free trial

Optina. FAQs

  • When was Optina. founded?

    Optina. was founded in 2011.

  • Where is Optina. headquartered?

    Optina. is headquartered in Montreal, Canada.

  • What is the size of Optina.?

    Optina. has 29 total employees.

  • What industry is Optina. in?

    Optina.’s primary industry is Decision/Risk Analysis.

  • Is Optina. a private or public company?

    Optina. is a Private company.

  • What is Optina.’s current revenue?

    The current revenue for Optina. is .

  • How much funding has Optina. raised over time?

    Optina. has raised $33.7M.

  • Who are Optina.’s investors?

    CABHI, Alzheimers Drug Discovery Foundation, Keihanna Global Acceleration Program, Alfin Asset Management, and Boehringer Ingelheim Venture Fund are 5 of 23 investors who have invested in Optina..

  • Who are Optina.’s competitors?

    Nucleix, Inivata, and ROCA Test are competitors of Optina..

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »